0001325618 false 0001325618 2021-06-11 2021-06-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT Pursuant

to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 11, 2021

 

IRADIMED CORPORATION

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-36534   73-1408526
(Commission File Number)   (IRS Employer Identification No.)

 

1025 Willa Springs Dr., Winter Springs, FL   32708
(Address of Principal Executive Offices)   (Zip Code)

 

(407) 677-8022

(Registrant’s Telephone Number, Including Area Code)

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol   Name of each exchange on which registered:
Common stock, par value $0.0001   IRMD   NASDAQ Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

The Annual Meeting of Stockholders of Iradimed Corporation (“Iradimed”) was held on Friday, June 11, 2021. At the meeting, Iradimed’s stockholders voted on the following four proposals and cast their votes as described below.

 

1.Stockholders elected each of Roger Susi, Monty Allen, Anthony Vuoto and James Hawkins to Iradimed’s Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director’s successor shall have been duly elected and qualified (or, if earlier, such director’s removal or resignation from our Board), as set forth below.

 

Name  Votes For   Votes Withheld   Broker
Non-Votes
 
Roger Susi   8,884,598    1,424,979    1,096,291 
Monty Allen   8,746,356    1,563,221    1,096,291 
Anthony Vuoto   9,800,266    509,311    1,096,291 
James Hawkins   9,799,167    510,410    1,096,291 

 

2.Stockholders ratified the selection of RSM US LLP as Iradimed’s independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2021, as set forth below.

 

Votes For   Votes Against   Abstentions 
 11,336,652    40,421    28,795 

 

3.Stockholders approved an advisory resolution on the compensation of Iradimed’s named executive officers.

 

Votes For   Votes Against   Abstentions   Broker Non-
Votes
 
 10,215,141    63,093    31,343    1,096,291 

 

4.Stockholders voted, on an advisory basis, on the frequency of future advisory votes on executive compensation.

 

1 Year   2 Years   3 Years   Abstentions 
 10,197,252    1,548    80,714    30,063 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 IRADIMED CORPORATION

 

Date: June 14, 2021

 

By:/s/Chris Scott
 Name:Chris Scott
 Title:Chief Financial Officer